Mirum Pharmaceuticals Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Mirum Pharmaceuticals Stock Summary

Mirum Pharmaceuticals competes with Immunocore Holdings, Larimar Therapeutics, Kalvista Pharmaceuticals, Lyra Therapeutics, and Terns Pharmaceuticals. Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. Mirum Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Foster City, California. Mirum Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 171 people.

Mirum Pharmaceuticals Key Financial Ratios

Mirum Pharmaceuticals Key Balance Sheet Accounts

Mirum Pharmaceuticals Key Income Statement Accounts

Mirum Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Mirum Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Mirum Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mirum Pharmaceuticals competition to find correlations between indicators driving Mirum Pharmaceuticals's intrinsic value. More Info.Mirum Pharmaceuticals is rated below average in return on equity category among its peers. It is regarded second in return on asset category among its peers . At this time, Mirum Pharmaceuticals' Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Mirum Pharmaceuticals by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Mirum Pharmaceuticals Systematic Risk

Today, most investors in Mirum Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Mirum Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Mirum Pharmaceuticals growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Mirum Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Mirum Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Mirum Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Mirum Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Mirum Pharmaceuticals's daily price indicators and compare them against related drivers.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mirum Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Mirum Stock, please use our How to Invest in Mirum Pharmaceuticals guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mirum Pharmaceuticals. If investors know Mirum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mirum Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Mirum Pharmaceuticals is measured differently than its book value, which is the value of Mirum that is recorded on the company's balance sheet. Investors also form their own opinion of Mirum Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Mirum Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mirum Pharmaceuticals' market value can be influenced by many factors that don't directly affect Mirum Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Mirum Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mirum Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mirum Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.